To identify and summarise the evidence of acupuncture/moxibustion and acupressure interventions for the prevention of stroke for those people at greatest risk of stroke.
Review question(s)
To identify and summarise the evidence of acupuncture/moxibustion and acupressure interventions for the prevention of stroke for those people at greatest risk of stroke.
Searches
Sources: MEDLINE, CINAHL/EBSCO, Scopus, Google Scholar, and Cochrane Database of Systematic Reviews.
Search terms relevant to 'acupuncture', 'moxibustion', and 'acupressure' as well as terms regarding a range of 'stroke risk factors' including high blood pressure, high cholesterol, irregular pulse, transient ischaemic attack, diabetes, and obesity.
Restrictions: peer-reviewed English language journal articles published from 1996 to 2016.
Types of study to be included
Randomised controlled trials and cross-over studies. 
Condition or domain being studied

Participants/ population
General population for stroke prevention and those with increased stroke risk due to hypertension, diabetes, hypercholesterolemia, overweight or obesity, atrial fibrillation, and/or transient ischaemic attack.
Intervention(s), exposure(s)
Inclusion criteria: any acupuncture, moxibustion, acupressure interventions. There is no limitation on the forms of acupuncture, moxibustion, and acupressure (e.g. auricular acupuncture, electroacupuncture, laser acupuncture, acupoint stimulation) and the frequency and duration of the intervention.
Comparator(s)/ control
Page: 1 / 4 Any comparator(s)/control.
Outcome(s)
Primary outcomes 1. Stroke incidence rate for stroke prevention trials.
2. Blood pressure for hypertension trials.
3. Triglycerides and total/LDL/HDL cholesterol for hypercholesterolemia trials.
4. Weight, body mass index, waist/hip circumference, and body fat for overweight/obesity trials.
5. Insulin, fasting or postprandial blood glucose, HbA1c and the HOMA index for diabetes trials.
6. Irregular pulse for atrial fibrillation trials.
7. Transient ischaemic attack trials.
Safety for all trials.
Secondary outcomes
None.
Data extraction, (selection and coding)
Titles and abstracts of all citations via initial search will be imported to Endnote and duplicates will be removed. Two authors will independently screen all these information to identify articles meeting the inclusion and exclusion criteria. Abstracts mentioning the key words will be selected for full-text review. All unclear studies will be assessed by a third author. In addition, one author will screen the reference lists of papers included in this systematic review paper.
Two authors will independently extract data into a pre-determined data extraction form. Differences in data extraction and interpretation will be resolved through discussion amongst all authors. The form will include information on country/year, sample characteristics, intervention, outcome measure(s), results, limitations, and side effects.
Risk of bias (quality) assessment
Two authors will independently assess risk of bias using the Cochrane Risk of Bias Tool for selection bias (random sequence generation and allocation concealment), performance bias (blinding of participants and personnel), detection bias (blinding of outcome assessment), attrition bias (incomplete outcome data), reporting bias (selective outcome reporting), and other sources of bias. Disagreements will be resolved through discussion with a third author.
The risk of bias assessment will be used to conduct sensitivity analyses to identify the level (high/low/unclear) of bias of each included study.
Strategy for data synthesis
The narrative (descriptive) synthesis will be undertaken on eligible studies.
